New 13D20
New 13G71
Stated intents0
The week of 2026-08-31, 20 holders filed a new Schedule 13D and 71 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-01 | Nutra Pharma Corp | Pure Raw Supplies, LLC | 100% | SCHEDULE 13D |
| 2026-09-04 | Bioforce Nanosciences Holdings, Inc. | Nexus Capital Investments, Inc. | 79.6% | SCHEDULE 13D |
| 2026-08-31 | Etoiles Capital Group Co., Ltd | Etoiles Zeneo Investment Ltd | 68.08% | SCHEDULE 13D |
| 2026-09-02 | Definitive Healthcare Corp. | Advent International, L.P. | 58.54% | SCHEDULE 13D |
| 2026-08-31 | LeonaBio, Inc. | Sermonix Pharmaceuticals, Inc. | 36.9% | SCHEDULE 13D |
| 2026-09-04 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 32.3% | SCHEDULE 13D |
| 2026-08-31 | Southern Cross Acquisition II Corp. | Southern Cross Acquisition II Sponsor Corp. | 27.75% | SCHEDULE 13D |
| 2026-08-31 | Starfighters Space, Inc. | Richard William Svetkoff | 23.85% | SCHEDULE 13D |
| 2026-09-03 | JATT III Acquisition Corp | JATT Ventures III L.P. | 22.1% | SCHEDULE 13D |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 21.3% | SCHEDULE 13D |
| 2026-09-04 | Radiopharm Theranostics Limited | Lantheus Holdings, Inc. | 20.9% | SCHEDULE 13D |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 20.4% | SCHEDULE 13D |
| 2026-09-03 | Dynaresource, Inc. | Nichol Gareth | 20.17% | SCHEDULE 13D |
| 2026-09-02 | Definitive Healthcare Corp. | Jason Ronald Krantz | 17.6% | SCHEDULE 13D |
| 2026-09-03 | Pasqal Holding SA | Bpifrance Participations S.A. | 11.4% | SCHEDULE 13D |
| 2026-09-03 | SkyAI, Inc. | Bastion Trading Limited | 9.9% | SCHEDULE 13D |
| 2026-09-03 | KLX Energy Services Holdings, Inc. | Steel Partners Holdings L.P. | 8.9% | SCHEDULE 13D |
| 2026-09-04 | VolitionRx Limited | Lagoda Investment Management, L.P. | 7.4% | SCHEDULE 13D |
| 2026-09-03 | Nexalin Technology, Inc. | Greenlight Ventures, LLC | 5.6% | SCHEDULE 13D |
| 2026-09-02 | Dynatrace, Inc. | Pictet Asset Management Sa | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-03 | Dimensional ETF Trust | First Command Advisory Services, Inc. | 37.8% | SCHEDULE 13G |
| 2026-09-02 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 23.15% | SCHEDULE 13G |
| 2026-09-02 | Calamos Global Dynamic Income Fund | Thrivent Financial For Lutherans | 22.8% | SCHEDULE 13G |
| 2026-09-02 | Calamos Dynamic Convertible & Income Fund | Thrivent Financial For Lutherans | 21.4% | SCHEDULE 13G |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 19.2% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Origin Force Intelligence Limited | 18.3% | SCHEDULE 13G |
| 2026-09-01 | Freenome, Inc. | Roche Holdings, Inc. | 17.4% | SCHEDULE 13G |
| 2026-09-04 | Radiopharm Theranostics Limited | Lantheus Omega, LLC | 17.3% | SCHEDULE 13G |
| 2026-09-02 | Bluemount Holdings Ltd | Siu Hiu Ki Jamie | 16.2% | SCHEDULE 13G |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 14.3% | SCHEDULE 13G |
| 2026-09-04 | Adi Global Distribution Inc | BlackRock, Inc. | 13.5% | SCHEDULE 13G |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 12.2% | SCHEDULE 13G |
| 2026-09-03 | Rainier Acquisition Corporation | 683 Capital Management, LLC | 11.2% | SCHEDULE 13G |
| 2026-09-03 | Rainier Acquisition Corporation | 683 Capital Management, LLC | 11.2% | SCHEDULE 13G |
| 2026-09-04 | Tcw Specialty Lending LLC | First Trust Capital Management L.P. | 11.19% | SCHEDULE 13G |
| 2026-09-04 | Myriad Genetics Inc | BlackRock Portfolio Management LLC | 10.4% | SCHEDULE 13G |
| 2026-09-04 | iShares S&P GSCI Commodity-Indexed Trust | BlackRock Portfolio Management LLC | 10.4% | SCHEDULE 13G |
| 2026-09-02 | Mint Inc Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-09-02 | Glucotrack, Inc. | White Lion Capital LLC | 9.99% | SCHEDULE 13G |
| 2026-09-04 | Conexeu Sciences Inc. | Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund | 9.99% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Orbis BioCapital Limited | 9.98% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Whitmore Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Horizon Ridge Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Clever Way Global Limited | 9.96% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Meridian Prosperous Limited | 9.96% | SCHEDULE 13G |
| 2026-08-31 | Royalty Management Holding Corp | Liberty Hill Capital Management, LLC | 9.95% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Star Voyage International Limited | 9.94% | SCHEDULE 13G |
| 2026-09-02 | CDT Equity Inc. | Taylor Mark Andrew | 9.6% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | August Luck Global Limited | 9.29% | SCHEDULE 13G |
| 2026-09-03 | C3is Inc. | Horne Timothy P | 9.1% | SCHEDULE 13G |
| 2026-09-03 | Avantis Responsible International Equity Etf | First Command Advisory Services, Inc. | 8.4% | SCHEDULE 13G |
| 2026-09-02 | Greenland Mines Ltd | Davidson Kempner Capital Management LP | 8.32% | SCHEDULE 13G |
| 2026-09-02 | ZeroStack Corp. | Puple AI Inc. | 8.3% | SCHEDULE 13G |
| 2026-09-04 | ZeroStack Corp. | Blockcat Pte. Ltd. | 8.3% | SCHEDULE 13G |
| 2026-09-04 | Arbutus Biopharma Corp | Whitefort Capital Master Fund, LP | 8% | SCHEDULE 13G |
| 2026-09-03 | Invesco Exchange-Traded Self-Indexed Fund Trust | First Command Advisory Services, Inc. | 7.8% | SCHEDULE 13G |
| 2026-09-04 | New Century Logistics (BVI) Ltd | Chen Xueyi | 7.78% | SCHEDULE 13G |
| 2026-09-03 | Pediatrix Medical Group, Inc. | Vanguard Portfolio Management | 7.55% | SCHEDULE 13G |
| 2026-09-03 | Zions Bancorporation, National Association | Vanguard Portfolio Management | 7.4% | SCHEDULE 13G |
| 2026-09-02 | Turtle Beach Corp | 22NW Fund, LP | 7.29% | SCHEDULE 13G |
| 2026-08-31 | Femasys Inc | Stonepine Capital Management, LLC | 7.2% | SCHEDULE 13G |
| 2026-09-03 | Royalty Management Holding Corp | Midwest General Investment Co LLC | 7% | SCHEDULE 13G |
| 2026-09-04 | Pasqal Holding SA | Inflection Point Fund I, LP | 7% | SCHEDULE 13G |
| 2026-09-03 | Spdr Index Shares Funds | First Command Advisory Services, Inc. | 6.9% | SCHEDULE 13G |
| 2026-09-02 | Tat Technologies Ltd | Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD | 6.25% | SCHEDULE 13G |
| 2026-09-01 | Rush Street Interactive, Inc. | Divisadero Street Capital Management, LP | 6.2% | SCHEDULE 13G |
| 2026-09-02 | JATT III Acquisition Corp | Deep Track Capital, LP | 5.83% | SCHEDULE 13G |
| 2026-09-02 | JATT III Acquisition Corp | Great Point Partners, LLC | 5.83% | SCHEDULE 13G |
| 2026-09-03 | Cal-Maine Foods Inc | Vanguard Portfolio Management | 5.75% | SCHEDULE 13G |
| 2026-09-04 | Karyopharm Therapeutics Inc. | Integrated Core Strategies (US) LLC | 5.7% | SCHEDULE 13G |
| 2026-09-02 | Bitgo Holdings, Inc. | Nydig Ihc LLC | 5.46% | SCHEDULE 13G |
| 2026-08-31 | Katapult Holdings, Inc. | Advantage Insurance Inc. | 5.4% | SCHEDULE 13G |
| 2026-09-03 | Liberty Media Corp | Vanguard Capital Management | 5.35% | SCHEDULE 13G |
| 2026-08-31 | Evolus, Inc. | Soleus Capital Master Fund, L.P. | 5.3% | SCHEDULE 13G |
| 2026-09-01 | Fortress Biotech, Inc. | Integrated Core Strategies (US) LLC | 5.3% | SCHEDULE 13G |
| 2026-09-03 | iShares Enhanced Large Cap Core Active ETF | First Command Advisory Services, Inc. | 5.3% | SCHEDULE 13G |
| 2026-09-03 | Zions Bancorporation, National Association | Vanguard Capital Management | 5.25% | SCHEDULE 13G |
| 2026-09-03 | FTAI Aviation Ltd. | Vanguard Capital Management | 5.22% | SCHEDULE 13G |
| 2026-09-03 | Molina Healthcare, Inc. | Giovanni Agnelli B.V. | 5.21% | SCHEDULE 13G |
| 2026-09-01 | Rainier Acquisition Corporation | MMCAP International Inc. SPC | 5.2% | SCHEDULE 13G |
| 2026-09-02 | JATT III Acquisition Corp | Commodore Capital LP | 5.2% | SCHEDULE 13G |
| 2026-09-03 | Biovie Inc. | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2026-09-03 | BellRing Brands, Inc. | Vanguard Capital Management | 5.2% | SCHEDULE 13G |
| 2026-09-04 | X-Energy, Inc. | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2026-09-03 | Pediatrix Medical Group, Inc. | Vanguard Capital Management | 5.15% | SCHEDULE 13G |
| 2026-09-03 | BellRing Brands, Inc. | Vanguard Portfolio Management | 5.11% | SCHEDULE 13G |
| 2026-09-04 | Liberty Media Corp | Vanguard Capital Management | 5.11% | SCHEDULE 13G |
| 2026-09-01 | New ERA Energy & Digital, Inc. | Mccarthy Kent C | 5.1% | SCHEDULE 13G |
| 2026-09-03 | JATT III Acquisition Corp | RA Capital Management, L.P. | 5.1% | SCHEDULE 13G |
| 2026-09-04 | Pg&E Corporation | SteelMill Master Fund LP | 5.1% | SCHEDULE 13G |
| 2026-09-03 | XTI Aerospace, Inc. | Patrick Green Harrington | 5.08% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)91 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.